3 August 2016

Holding(s) in Company

 

Read more

2 August 2016

Holding(s) in Company

 

Read more

2 August 2016

Holding(s) in Company - Replacement

The following announcement replaces the notification Ref 9994F issued on 2 August 2016. The amendment is to Section 9 which should read as follows: The voting rights are managed and controlled by Edmond de Rothschild Investment Partners, acting in its capacity of manage…

Read more

1 August 2016

Holding(s) in Company

 

Read more

1 August 2016

Holding(s) in Company



Read more

1 August 2016

Holding(s) in Company

 

Read more

29 July 2016

VERONA PHARMA PLC - Admission of Placing Shares

PR Newswire

Read more

22 July 2016

Result of GM

PR Newswire

Read more

1 July 2016

Notice of GM

PR Newswire

Read more

27 June 2016

Result of AGM

PR Newswire

Read more

Innovative Therapies for Respiratory Care

See the 2017 Verona Pharma corporate video 2017

Runtime: 04:05

Go

Basic & Clinical Pharmacology & Toxicology

Peer-reviewed publication on dual PDE3/4 inhibitors as novel treatments for COPD

The Lancet Respiratory Medicine

Peer-reviewed paper in the Lancet's highly-respected medication journal

Close

Verona Pharma plc
3 More London Riverside, London SE1 2RE
T: +44 (0)203 283 4200

Linkedin     Email Us